10 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... , a half B-profile ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... with lung-rockets ... B profile is a half ... , a half B-profile ... www.grepmed.com/images/11924/dyspnea-criticalcare-pulmonary-algorithm-pocus
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... , a half B-profile ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... Chronic Obstructive Lung ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... antagonists; LABA: long-acting ... Management #Stepwise #Pulmonary ... #StepUp #Treatment ... #Algorithm #Guidelines
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... hallucinations, rashes/long-term ... , prolonged half-life ... fever, chills, dyspnea ... valleyfever #management #treatment
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... hallucinations, rashes/long-term ... , prolonged half-life ... fever, chills, dyspnea ... pharmacology #management #treatment
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... • Amiodarone half ... starting amiodarone treatment ... Dyspnea 3. ... macrophages Treatment
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
goals of assessing lung ... and relief of dyspnea ... the patient’s dyspnea ... #Algorithm #Effusion ... Management #Pleural #Pulmonary
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
syndromes current treatment ... algorithm 2018. ... cardiovascular or pulmonary ... Network (NCCN) guidelines ... #algorithm #hematology